- Consumer Products
- Latest 17.55
- Currency US$
- Change 1.00
- Percent Change 6.042 %
- Volume 216,923
- Tue Jun 18, 2013 4:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||May 1||$0.17||Aug 7||$0.29|
12 months ended Jun 19, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products and devices that promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid, a naturally-occurring, biocompatible polymer found in the body. Due to its unique properties, hyaluronic acid plays an important role in numerous physiological functions such as the protection and lubrication of soft tissues and joints, the maintenance of the structural integrity of tissues and the transport of molecules to and within cells.